Reports for OLMESARTAN MEDOXOMIL
Ingredient
OLMESARTAN MEDOXOMIL
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACH-OLMESARTAN | 40MG | TABLET | Resolved | 2023-02-24 | 2023-03-07 | 185586 |
| ACH-OLMESARTAN | 40MG | TABLET | Actual shortage | 2024-01-19 | 2024-01-19 | 216791 |
| ACH-OLMESARTAN | 40MG | TABLET | Actual shortage | 2024-04-19 | 2024-04-20 | 225694 |
| OLMESARTAN | 40MG | TABLET | Resolved | 2023-07-31 | 2023-09-25 | 200456 |
| OLMESARTAN | 40MG | TABLET | Resolved | 2023-10-23 | 2024-02-12 | 207885 |
| OLMESARTAN | 40MG | TABLET | Actual shortage | 2024-03-11 | 2024-03-11 | 221872 |
| APO-OLMESARTAN | 40MG | TABLET | Resolved | 2017-07-31 | 2018-01-20 | 17614 |
| APO-OLMESARTAN | 40MG | TABLET | Resolved | 2018-07-11 | 2020-09-01 | 55287 |
| APO-OLMESARTAN | 40MG | TABLET | Anticipated shortage | 2024-01-19 | 2024-01-19 | 216714 |
| OLMETEC | 40MG | TABLET | Resolved | 2019-03-04 | 2019-05-09 | 77362 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-OLMESARTAN / HCTZ | 20MG 12.5MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117513 |
| AURO-OLMESARTAN | 20MG | TABLET | Discontinued | 2023-11-21 | 2023-11-22 | 210984 |
| PMS-OLMESARTAN | 20MG | TABLET | Discontinued | 2021-11-16 | 2021-11-16 | 149385 |
| TEVA-OLMESARTAN | 20MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117497 |
| RIVA-OLMESARTAN | 20MG | TABLET | Discontinued | 2019-04-17 | 2019-04-18 | 81926 |
| TEVA-OLMESARTAN / HCTZ | 40MG 12.5MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117516 |
| TEVA-OLMESARTAN / HCTZ | 40MG 25MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117519 |
| AURO-OLMESARTAN | 40MG | TABLET | Discontinued | 2023-11-21 | 2023-11-22 | 210987 |
| PMS-OLMESARTAN | 40MG | TABLET | Discontinued | 2021-11-16 | 2021-11-16 | 149388 |
| TEVA-OLMESARTAN | 40MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117500 |